ArticleCurrent microbiology2024
The Reverse Ecology-Based Approach to Design a Bacterial Consortium as Soybean Bioinoculant.
Article in Current microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A 'Genome-First' Framework for Next-Generation Bioinputs: From Functional Mining to Rational Synthetic Microbial Communities.Environmental microbiology · 2026Review
- From cultivation challenges of Acidobacteriota to biotechnological promises - unveiling what is needed to fully harness their potential.World journal of microbiology & biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Bioinoculants traditionally rely on selecting efficient microbes from the soil with potential growth-enhancing traits for plants. However, such approaches often neglect microbe-microbe and microbe-plant interactions. In this study, we applied a reverse ecology framework to design and assess a bacterial consortium tailored for soybeans. Our analysis identified Paenibacillus polymyxa, Methylobacterium brachiatum, and Enterobacter sp. as key strains for their synergistic potential in promoting soybean growth. Computational analyses revealed that these selected strains exhibited low competitiveness and metabolic compatibility. Specifically, their complementary metabolic profiles suggested minimal competition for resources and potential for mutualistic interactions. In vitro experiments further supported these findings, demonstrating that the consortium maintained stable growth without inhibitory effects among strains. In addition, greenhouse validation experiments confirmed the efficacy of the microbial consortium in enhancing soybean growth such as root and shoot development and biomass production. Overall, this study underscores the potential of reverse ecology in optimizing microbial consortia design for bioinoculant applications.
Indexed as
Identifiers
39438288What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.